You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 8, August 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intravenous Desensitization to Mechlorethamine in Patients With Psoriasis

David M. Pariser, MD; Richard C. Childers, MD; Paul Kechijian, MD; Kenneth M. Halprin, MD; J. Richard Taylor, MD

Arch Dermatol. 1976;112(8):1113-1114.


Abstract

• Eight patients with psoriasis who had developed contact allergy to mechlorethamine hydrochloride (nitrogen mustard) were subjected to a regimen of intravenous infusion of small amounts of the drug in an attempt to produce desensitization. Although three of eight developed negative patch tests and were presumed to be desensitized, only one patient was able to use the drug therapeutically, and then only for a period of eight months, after which allergy recurred. The other two patients whose allergic contact dermatitis was abolished by the infusions were unable to use mechlorethamine therapeutically because of pruritus. Seven patients experienced some adverse reaction to the infusion.

Intravenous desensitization of psoriatic patients who are allergic to mechlorethamine was not successful enough as a useful clinical procedure to allow them to once again use the drug therapeutically.

(Arch Dermatol 112:1113-1114, 1976)



Author Affiliations

From the Department of Dermatology, University of Miami School of Medicine and the Veterans Administration Hospital, Miami. Dr Pariser is now in private practice in Norfolk, Va; Dr Childers is in private practice in Gainesville, Fla; Dr Kechijian is now at the Skin and Cancer Unit, New York University School of Medicine, New York.


Footnotes

Accepted for publication Nov 28, 1975.

Reprint requests to 403 Medical Tower, Norfolk, VA 23507 (Dr Pariser).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Prospective Study of Cutaneous Intolerance to Topical Mechlorethamine Therapy in Patients With Cutaneous T-Cell Lymphomas
Esteve et al.
Arch Dermatol 1999;135:1349-1353.
ABSTRACT | FULL TEXT  

The Treatment of Mycosis Fungoides With Ointment-Based Mechlorethamine
Price et al.
Arch Dermatol 1982;118:234-237.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.